BCAB
BioAtla Inc.
Company Overview
| Mkt Cap | $36.52M | Price | $0.70 |
| Volume | 275.04K | Change | +0.66% |
| P/E Ratio | -0.5 | Open | $0.71 |
| Revenue | $11.0M | Prev Close | $0.69 |
| Net Income | $-69.8M | 52W Range | $0.24 - $2.53 |
| Div Yield | N/A | Target | $10.00 |
| Overall | 37 | Value | 40 |
| Quality | 31 | Technical | 41 |
No chart data available
Stock Overview
Updated DailyBioAtla Inc. (BCAB) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $0.70 with a market capitalization of $36.52 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BCAB with a volume of 275K shares. The stock opened up 1.73% from yesterday's close of $0.69. Current analyst estimates project earnings of $-1.3 per share for this year, with next year targeting $-1.59.
BCAB demonstrates weak technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for BCAB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 1329.8%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 03:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAB | $0.70 | +0.7% | 275.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |